Gotham Asset Management, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1510387
NEW YORK, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,430,915
+$104,035 QoQ
Shares Held
18,986
-9.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#380
of 1,735 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $433,918,027 across 48 Biotechnology names. VRTX ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
719,545 | $81,567,621 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105,165 | $65,574,584 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
739,273 | $57,862,897 | |
| 4 | EXEL |
Exelixis, Inc.
|
892,663 | $48,569,793 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
1,349,465 | $47,757,566 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
112,014 | $26,992,013 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
120,702 | $22,605,070 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
42,051 | $12,658,612 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,430,915 | 18,986 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,326,880 | 20,887 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,752,226 | 21,511 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,572,216 | 21,888 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,507,691 | 21,356 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,466,845 | 27,777 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,125,699 | 30,111 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,619,015 | 27,133 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,582,539 | 24,711 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,657,107 | 18,318 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,954,970 | 17,093 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,208,001 | 12,101 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,030,425 | 11,453 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,772,963 | 11,975 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,433,197 | 25,740 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,888,730 | 37,607 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,120,060 | 28,816 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,171,455 | 27,480 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,996,998 | 22,755 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,676,231 | 20,267 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,320,177 | 36,305 | Shares | Sole | 2021-08-16 | |
| 2020-09-30 | $415,527 | 1,527 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $445,625 | 1,535 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $471,616 | 1,982 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||